Cargando…
PS141. Depressive Symptoms, as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1
Autores principales: | Murakami, Yuki, Tomita, Eiichi, Nishikawa, Makiya, Mouri, Akihiro, Kubo, Hisako, Yamamoto, Yasuko, Kim, Hyoung-Chun, Nabeshima, Toshitaka, Saito, Kuniaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616737/ http://dx.doi.org/10.1093/ijnp/pyw043.141 |
Ejemplares similares
-
Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1
por: Murakami, Yuki, et al.
Publicado: (2016) -
Indoleamine 2,3‐dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma
por: Yamasuge, Wakana, et al.
Publicado: (2019) -
Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling
por: Yamamoto, Yasuko, et al.
Publicado: (2018) -
Remarkable Role of Indoleamine 2,3-Dioxygenase and Tryptophan Metabolites in Infectious Diseases: Potential Role in Macrophage-Mediated Inflammatory Diseases
por: Murakami, Yuki, et al.
Publicado: (2013) -
Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation
por: Fujii, Kento, et al.
Publicado: (2020)